Anonymous Survey Researching 5-MeO-DMT Reactivation Experiences

With the popularization of 5-MeO-DMT as a powerful substance for self-exploration and reconnection with the essence of life, side effects such as the now-famous reactivations (flashbacks) have also been revealed.

By |2021-03-28T14:23:51-08:00March 28, 2021|5-MEO-DMT, Articles & News, DMT|0 Comments

FDA May Allow Trials for Algernon’s Psychedelic DMT

Canada-based Algernon announced its clinical program in January based in part on a preclinical study published last year in Experimental Neurology by researchers from Semmelweis University, which showed DMT can promote neurogenesis and neuroplasticity in a rat model of brain ischemia.

The Ultimate Guide to 4-ACO-DMT, Experience, Benefits & Side Effects

4-AcO-DMT (or psilacetin) is a semi-synthetic tryptamine closely related to the psychedelic mushroom molecules psilocin and psilocybin. In fact, 4-AcO-DMT is widely known as “synthetic mushrooms.” Like psilocybin, it appears that the body metabolizes 4-AcO-DMT into psilocin.

By |2021-03-31T12:00:48-08:00March 7, 2021|4-AcO-DMT, 5-MEO-DMT, DMT|0 Comments

Psychedelic Drugs Market 2021 Worth Observing Growth | Global Players – Klarisana, AstraZeneca, F. Hoffmann-La Roche, Dr. Reddy’s Laboratories

The Psychedelic Drugs market is growing rapidly due to the increasing prevalence of depression and other mental disorders worldwide. The need for handling environmental stress and enhanced and better quality of lifestyle is acting as a driver for the Psychedelic Drugs market.

Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study

Science in Action has confirmed that it has received ethics approval for an in vivo non-GLP toxicology study of N, N Dimethyltryptamine (DMT) (the "Study"). Both Entheon and Science in Action have applied for requisite permits in order to export, receive and research DMT drug product.

By |2021-02-22T23:05:28-08:00February 22, 2021|DMT, Psychedelic News, Studies|0 Comments

Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke Program

N,N-Dimethyltryptamine, or DMT, is a hallucinogenic tryptamine drug producing effects similar to those of other psychedelics like LSD, ketamine, psilocybin and psilocin. DMT occurs naturally in many plant species and animals and has been used in religious ceremonies as a traditional spiritual medicine by indigenous people in the Amazonian basin. DMT can also be synthesised in a laboratory.

By |2021-02-20T01:02:20-08:00February 20, 2021|Articles & News, DMT|0 Comments

California Would Legalize Possession Of Psychedelics Like LSD, DMT And Psilocybin Under New Senate Bill

Possession of psychedelics such as psilocybin mushrooms, LSD and DMT would be legalized in California under a new Senate bill that was introduced on Wednesday.

MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds

– MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with psychedelic or empathogenic properties.

By |2021-02-11T19:20:25-08:00February 11, 2021|Articles & News, DMT|0 Comments

What Happens To Our Brains When Taking Hallucinogenics Like Ayahuasca?

While some substances like ketamine and LSD have been extensively studied, researchers are now looking at other overlooked psychedelics, including a South American substance called ayahuasca, a potent beverage historically linked to peoples and tribes of the Amazon rainforest.

By |2019-12-01T23:57:46-08:00December 1, 2019|Articles & News, Ayahuasca, DMT, LSD, Magic Mushrooms|0 Comments

Go to Top